Publication:
An open-label trial to assess the safety of regorafenib in Turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)

Simple item page
dc.contributor.authorsDane, F.; Ozgurdal, K.; Yalcin, S.; Benekli, M.; Aykan, N. F.; Yucel, I.; Ozkan, M.; Evrensel, T.; Sevinc, A.; Coskun, H. S.; Sanli, U. S.; Kara, I. O.
dc.date.accessioned2022-03-12T04:20:19Z
dc.date.accessioned2026-01-11T08:32:41Z
dc.date.available2022-03-12T04:20:19Z
dc.date.issued2015-06
dc.identifier.doi10.1093/annonc/mdv233.253
dc.identifier.eissn1569-8041
dc.identifier.issn0923-7534
dc.identifier.urihttps://hdl.handle.net/11424/223730
dc.identifier.wosWOS:000357047400123
dc.language.isoeng
dc.publisherOXFORD UNIV PRESS
dc.relation.ispartofANNALS OF ONCOLOGY
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleAn open-label trial to assess the safety of regorafenib in Turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.titleANNALS OF ONCOLOGY
oaire.citation.volume26

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
43.39 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları